Ligand pharmaceuticals incorporated

Major-Pharmaceuticals

LGND


3911 Sorrento Valley Boulevard
San Diego , CA 92121

Executive/
Director

Price

  • Last Close
  • $ 124.26
    $ +0.55 0.44 %
    Dec 6, 2024
  • 52-Week High/Low
  • $109.17 - $49.57
  • YTD
  • 74%

  • Trading Volume
  • 3,637
  • Market Cap Full
  • $ 2.2B
  • Shares Outstanding
  • 17.4M
    Nov 6, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 44.9% -1.2% 4.2% 20.6% -7.4% -5% 58.2% -28.7% 10.1% 2.4%
Q2 30.9% 11.4% 14.7% 29.4% -7.9% 4% -16.3% -20.7% -2% -0.5%
Q3 -15.1% -14.4% 12.2% 30% -13.2% 8% 6.2% -39.8% -16.9% -
Q4 26.6% -0.4% 0.7% -50.1% 5.3% 1.7% 13.3% 24.4% 20.7% -
J F M A M J J A S O N D
2024 2.4% 8.6% -7.9% 0.2% - - - - - - - -
2023 4.3% 3.5% 2% 3.8% -8.2% 2.9% -7.2% -1.7% -8.9% -12.7% 11.5% 22.5%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    1%104%-6%35%-1%-23%-6%59%-58%7%74%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.20 0.77 0.39 1.83 31.32 -1.46 1.05 -0.91 2.33
Q2 1.63 0.17 0.54 2.99 -0.74 1.32 1.79 -0.05 0.13
Q3 0.42 0.03 0.55 2.8 -0.81 -0.42 0.8 0.02 -0.59
Q4 0.52 0.15 1.03 -1.66 -0.43 0.35 -0.3 -1.04 -
A 2.8 1.1 2.5 6 31.9 -0.2 3.3 -2 1.87

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 20.4 16.5 16.6 16.9 17.1
Jun 21.3 19.6 16 16.7 16.9 17.3
Sep 21.1 19 16.1 16.7 16.9 17.4
Dec 21.3 17.6 16.1 16.7 16.9 17.4

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - 0.2 0.4 0.6
Total Asset Turnover - - 0.1 0.1 0.2
Leverage
Interest Coverage - - 0.9 4.5 8
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Equity multiplier - - - - -